Reynders McVeigh Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Reynders McVeigh Capital Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-12,174	Closed	-$547K	–	239
2021 Q1	$547K	Sell	12,174 -4,721	-28%	-$212K	0.04%	147
2020 Q4	$955K	Buy	16,895 +785	+5%	+$44.4K	0.07%	105
2020 Q3	$764K	Sell	16,110 -530	-3%	-$25.1K	0.06%	117
2020 Q2	$981K	Sell	16,640 -1,750	-10%	-$103K	0.09%	103
2020 Q1	$869K	Sell	18,390 -2,200	-11%	-$104K	0.1%	97
2019 Q4	$1.24M	Hold	20,590	–	–	0.12%	93
2019 Q3	$1.23M	Sell	20,590 -1,520	-7%	-$91.1K	0.13%	92
2019 Q2	$1.42M	Buy	22,110 +150	+0.7%	+$9.64K	0.15%	84
2019 Q1	$1.78M	Buy	21,960 +3,400	+18%	+$276K	0.2%	73
2018 Q4	$1M	Buy	18,560 +10,500	+130%	+$567K	0.13%	94
2018 Q3	$416K	Sell	8,060 -5,035	-38%	-$260K	0.05%	147
2018 Q2	$546K	Sell	13,095 -625	-5%	-$26.1K	0.07%	129
2018 Q1	$605K	Sell	13,720 -225	-2%	-$9.92K	0.08%	125
2017 Q4	$701K	Sell	13,945 -425	-3%	-$21.4K	0.09%	113
2017 Q3	$729K	Sell	14,370 -1,625	-10%	-$82.4K	0.1%	110
2017 Q2	$814K	Sell	15,995 -1,150	-7%	-$58.5K	0.11%	108
2017 Q1	$689K	Sell	17,145 -4,275	-20%	-$172K	0.09%	120
2016 Q4	$1.03M	Sell	21,420 -10,740	-33%	-$514K	0.15%	99
2016 Q3	$1.18M	Sell	32,160 -25,823	-45%	-$946K	0.17%	89
2016 Q2	$1.35M	Sell	57,983 -54,814	-49%	-$1.28M	0.2%	84
2016 Q1	$4.57M	Buy	112,797 +275	+0.2%	+$11.1K	0.68%	37
2015 Q4	$6.97M	Buy	112,522 +1,209	+1%	+$74.9K	1.14%	26
2015 Q3	$4.5M	Buy	111,313 +925	+0.8%	+$37.4K	0.78%	33
2015 Q2	$6.35M	Sell	110,388 -1,330	-1%	-$76.5K	1.04%	28
2015 Q1	$7.11M	Buy	111,718 +1,235	+1%	+$78.6K	1.22%	27
2014 Q4	$6.82M	Buy	110,483 +2,625	+2%	+$162K	1.2%	29
2014 Q3	$4.19M	Buy	107,858 +37,575	+53%	+$1.46M	0.8%	35
2014 Q2	$2.42M	Buy	70,283 +49,203	+233%	+$1.69M	0.55%	42
2014 Q1	$911K	Buy	21,080 +12,915	+158%	+$558K	0.22%	79
2013 Q4	$325K	Buy	+8,165	New	+$325K	0.08%	132